Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects

por Moore, Kenneth Todd, Byra, William, Vaidyanathan, Seema, Natarajan, Jaya, Ariyawansa, Jay, Salih, Hiba, Turner, Kenneth C
Publicado 2015

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of deat...

por Zannad, Faiez, Greenberg, Barry, Cleland, John G.F., Gheorghiade, Mihai, van Veldhuisen, Dirk J., Mehra, Mandeep R., Anker, Stefan D., Byra, William M., Fu, Min, Mills, Roger M.
Publicado 2015

Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction

por Girerd, Nicolas, Cleland, John, Anker, Stefan D., Byra, William, Lam, Carolyn S. P., Lapolice, David, Mehra, Mandeep R., van Veldhuisen, Dirk J., Bresso, Emmanuel, Lamiral, Zohra, Greenberg, Barry, Zannad, Faiez
Publicado 2022

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMAN...

por Mehra, Mandeep R, Vaduganathan, Muthiah, Fu, Min, Ferreira, João Pedro, Anker, Stefan D, Cleland, John G F, Lam, Carolyn S P, van Veldhuisen, Dirk J, Byra, William M, Spiro, Theodore E, Deng, Hsiaowei, Zannad, Faiez, Greenberg, Barry
Publicado 2019